Clinical trials
Recruiting Triple Negative Breast Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Bristol-Myers Squibb | 2 |
| Cancer Research UK | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Epsilogen Ltd | 1 |
| Exelixis | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Breast Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Endometrial Neoplasms | 4 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.